Latest news with #JimmyLi
Eater
3 days ago
- Entertainment
- Eater
How to Spend a 24-Hour Staycation in Chinatown Las Vegas
Las Vegas's Chinatown rivals the Strip with its vibrant, around-the-clock dining scene. Centered along Spring Mountain Road just minutes west of the Strip, this neighborhood draws locals, industry workers, and food enthusiasts seeking diverse cuisines, most prominently from East Asia. Chinatown is packed with everything from casual noodle shops and street food stalls to upscale izakayas and innovative fusion spots. It's where many of Vegas's top chefs craft bold menus that may otherwise be too adventurous for Strip visitors, blending tradition with creativity without the crowds or high prices. During an action-packed one-day staycation, come hungry, starting with strong coffee, then venturing to decadent breakfast, afternoon dumplings, and late-night noodles. Spring Mountain Road delivers at almost every hour. With its accessibility, diversity, and unmistakable local energy, Chinatown is a must-visit destination to experience the true culinary heart of Las Vegas. Here's how to spend 24 hours drinking and dining through Las Vegas's Chinatown. 8 a.m. — Coffee at Gabi Coffee and Bakery Start your all-day food crawl with a caffeine fix at this locals' favorite Korean coffee shop. Hidden behind a heavy wooden door in an otherwise basic strip mall, Gabi Coffee opens into a cavernous, dreamlike ambience with antique furniture, tiered platforms for sitting on floor cushions at low tables, and a glass atrium that doubles as Gabi Cafe's bakery. Order colorful wedges of crepe cake dusted with powdered sugar, flaky chocolate croissants, and bacon potato quiche. Korean-style medium-roast coffee is aromatic and full-bodied with a lightly acidic flavor that works well in cappuccinos and lavender white mochas. Gabi Coffee and Bakery 9 a.m. — Breakfast at Guieb Cafe This Hawaii-based restaurant draws on Filipino flavors for bold, comforting breakfasts is a casual space adorned with surfer murals. The standout is a stack of purple pancakes slathered with creamy ube mascarpone and garnished with a purple orchid blossom. For those recovering from a late night, go for the prime rib loco moco: a juicy 10-ounce steak served over white rice, smothered in glossy, umami-heavy gravy, and finished with two fried eggs. If saving room for the rest of the food crawl, consider the oxtail soup — flavor-packed and herbaceous, it's loaded with tender meat and swirls of fresh cilantro. 12:30 p.m. — Lunch at Shanghai Taste Chef Jimmy Li of Shanghai Taste earned a James Beard Award nod for Best Chef: Southwest in 2023 — primarily for his delicately wrapped xiao long bao. The restaurant cranks out about 3,000 soup dumplings a day, each sporting savory broth and juicy pork suspended within tender, pleated satchels. The rest of the menu is like a love letter to Shanhainese street food — each dish deftly prepared and most under $15. Bean curd noodles in shrimp XO sauce have a rich chile flavor. Shanghai crispy shrimp is cooked with the shells on for extra crunch, and a beef stir fry is robust with bell peppers, onions, and oyster mushrooms in black pepper sauce. Mark down orders on paper menus and don't miss out on fried sheng jian bao, crispy scallion pancakes, and sticky-sweet pork ribs that fall off the bone. 3 p.m. — Happy Hour at Double Zero Pie and Pub One of the best pizzaiolos in Las Vegas is earning national attention at this Chinatown strip mall spot. Chef Michael Vakneen's dough starts with finely milled double-zero flour, fermented slowly with natural starters, then hand-stretched to preserve its structure. The result is a crust that's light, airy, and crisp, yet sturdy enough to carry bold toppings without turning soggy. Happy hour starts at 3 p.m. with snacks and drinks for $5 — but don't skip the full-sized pies. There's a white-sauce version with browned mushrooms and mozzarella that's earthy and creamy, or a sweet-savory standout topped with speck, fig jam, mozzarella, and candied pecans. Janna Karel 6 p.m. — Dinner at Sparrow and Wolf Chef Brian Howard cut his teeth in acclaimed kitchens like Comme Ça, Alizé, and Bouchon before opening Sparrow and Wolf, his genre-defying Chinatown flagship that blends fine-dining precision with fearless, globally inspired flavors. His seasonal tasting menus jump through the continents with ease, while a la carte options offer a more casual way to explore his boundary-pushing cooking. Standouts include Vietnamese bánh cuốn stuffed with savory duck and wrapped in black rice rolls, Spanish octopus over jet-black squid ink risotto, and honey-glazed pork secreto paired with sweet potato-banana purée. Howard's food is ambitious but unfussy — each dish layered with texture and contrast, without losing its soul. Let the kitchen lead with the tasting menu. Janna Karel 9 p.m. — Cocktails at the Golden Tiki The Golden Tiki is a 24-hour tropical escape, a celebration of maximalism, like Disneyland through an adults-only filter. If you survive the brutal parking lot, step through the dark passageway in the glow of animatronic birds, a twinkling Rainforest Cafe-style night sky, and a life-sized mermaid in glass that looks just real enough to call for a double-take. Bartender Adam Rains slings some of the best tiki drinks in town — classics like painkillers and banana batidas shine here. Plan in advance to reserve a table or just belly up to the bar. With drinks in hand, take a lap to admire the decor — dazzling waterfalls, head-scratching island artifacts, old-timey nudes tucked beneath glass table tops, and lewd wallpaper in the restrooms. The Golden Tiki 11 p.m. — Dessert at Ichiza Perched on the second floor of a shopping center, this izakaya is a Chinatown institution. The menu is scrawled on handwritten paper signs plastered onto every inch of wall space, offering a rotating lineup of specials, nigiri, and skewers that are available that week. But by 11 p.m., the mission is to order the honey toast. The cube of warm, buttery Japanese milk bread is crisped on the edges, filled with diced bites that are toasted to golden brown. It arrives piled high with scoops of vanilla ice cream and honey drizzle that melt into the cracks, glazing every bite with sticky-sweet cream and turning the whole thing into a gooey, golden mess. Wash it down with sparkling peach sake. A late-night bowl of pho at Pho Kim Long is a Las Vegas rite of passage. This Chinatown favorite may not serve the absolute best pho in town, but at 2 a.m., it's the one that matters most. Inside, the lights are bright, the tables are packed, and the crowd is a blur of off-shift chefs, bar hoppers, and industry regulars trickling in from the Strip for something hot and restorative. Start with crunchy chicken egg rolls for the table, then dive into a steaming bowl of beef pho — its deeply aromatic broth tangled with tender rice noodles, rare steak, and brisket. Dress it up with jalapeños, bean sprouts, and torn basil, then slurp it until bleary-eyed. The vibes in Pho Kim Long during the wee hours are like a sleepover party that's gone on too long — over-tired and buzzing, but mostly quietly content. Eater Vegas All your essential food and restaurant intel delivered to you Email (required) Sign Up By submitting your email, you agree to our Terms and Privacy Notice . This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Associated Press
01-07-2025
- Business
- Associated Press
WuXi XDC Announces the Mechanical Completion of its Singapore Site, Accelerating the Global Expansion of Bioconjugates Manufacturing
SHANGHAI and SINGAPORE, July 1, 2025 /PRNewswire/ -- On June 30, WuXi XDC Cayman Inc. ('WuXi XDC', stock code: a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, announced that the mechanical completion of its manufacturing site at Tuas Biomedical Park in Singapore has been successfully achieved. This milestone signifies that this manufacturing site, spanning approximately 25,000 square meters, will now officially transition into the facility C&Q (Commissioning and Qualification) stage. The Singapore site is expected to commence operations by the end of 2025 and Good Manufacturing Practice (GMP) manufacturing in 2026. Upon that, the site will offer comprehensive production capabilities from the preclinical stage to commercialization. As a critical component of WuXi XDC's global strategy, the Singapore site has demonstrated exceptional progress, adhering to the perfect execution and the 'WuXi Speed' to provide customers with agile and flexible end-to-end CRDMO services. According to current capacity plan, the site is anticipated to create more than 500 job opportunities and over 100 people have joined our company so far. Dr. Jimmy Li, CEO of WuXi XDC, stated, " The rapid mechanical completion of our Singapore site marks a critical pillar in our 'Global Dual-Sourcing' strategy. This global site will form a worldwide network alongside our Wuxi, Changzhou, and Shanghai sites, delivering end-to-end CRDMO services to global customers. This accomplishment showcases the full support of the partners for the construction of Singapore site, our deep understanding of global market demands, our ability to respond swiftly and the robust execution capabilities of our team. Looking ahead, we remain committed to advancing our one-stop model and global supply network, collaborating with global partners to promote the diversified and sustainable development of bioconjugates.' The Singapore site serves as a world-class, one-stop bioconjugates manufacturing center, integrating antibody intermediates, drug substance (DS), and drug products (DP). It strictly adheres to international certification standards and utilizes an advanced modular factory design. Key features include state-of-the-art antibody intermediates production lines, bioconjugate DS and DP production lines, MSAT lab, quality control, intelligent warehousing, and other utility support areas. Equipped with cutting-edge isolator filling lines, fully automated material transfer systems, and digital production management systems, the Singapore site supports multi-level demands ranging from small-scale clinical supplies to large-scale commercial manufacturing, including up to 2,000 liters per batch of mAb/DS, and 8 million vials of DP per year. These capabilities ensure the efficient advancement of projects across various stages while maintaining adherence to the highest quality standards. The Singapore site will be operated under the highest international quality assurance standards, fully complying with Good Manufacturing Practice (GMP) regulations established by the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and China's National Medical Products Administration (NMPA). This ensures comprehensive compliance throughout the production process, from antibody intermediates and DS to DP, enabling seamless product release globally. Additionally, the site incorporates environmentally friendly practices, utilizing certified eco-friendly products and implementing strict recycling and waste disposal systems to promote sustainability and enhance the company's ESG management level. About WuXi XDC WuXi XDC Cayman Inc. (stock code: is a globally recognized contract research, development, and manufacturing organization (CRDMO) specializing in bioconjugates. The company offers a wide range of innovative conjugation and payload-linker technologies to facilitate the development of next-generation antibody-drug conjugates (ADCs). Focused on early-stage research and development of ADCs and other bioconjugates, WuXi XDC offers comprehensive one-stop services from clinical to commercial manufacturing. Its services cover antibody intermediates and other biologics intermediates, chemical payloads and linkers, as well as bioconjugate drug substances and drug products. For more information about WuXi XDC, please visit: WuXi XDC Contacts Investor: [email protected] Media: [email protected] BD: [email protected] View original content: SOURCE WuXi XDC
Yahoo
13-03-2025
- Business
- Yahoo
WuXi XDC Wins Multiple Awards at Asia-Pacific Biopharma Excellence Awards 2025
SHANGHAI, March 13, 2025 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", or the "Company", stock code: a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugates, has been honored with four prestigious awards at the Asia-Pacific Biopharma Excellence Awards 2025. The Asia-Pacific Biopharma Excellence Awards honor companies annually that have exhibited outstanding performance and achievement in the biopharmaceutical sector. These accolades underscore WuXi XDC's leadership, innovation, and fully integrated CRDMO platform, empowering global clients from early discovery to commercial manufacturing. Industry-leading development and manufacturing capabilities (Best ADC CDMO in Asia & China): WuXi XDC's state-of-the-art facilities and global dual-sourcing strategy enable seamless CMC development and GMP manufacturing, accelerating the timeline while ensuring a high success rate and regulatory excellence. Innovation in Discovery & Development (Best ADC CRO in Asia): WuXi XDC's proprietary conjugation and payload-linker technologies, along with the incorporation of external technologies through partnerships, drive ADC and XDC discovery, optimization, and IND-enabling studies, expediting clients' clinical advancement. Pioneering ADC Technology (Best ADC Platform Technology): Through next-generation payload-linker innovations and site-specific conjugation technologies, from internal development and external partnership, WuXi XDC provides clients with diversified technology suites to advance ADC and XDC developments. Dr. Jimmy Li, CEO of WuXi XDC, commented: "We are honored to receive these prestigious awards, which not only reaffirm our team's relentless pursuit of excellence and innovation in the ADC field but also underscore our dedication to delivering world-class services that empower our clients to bring novel therapies to patients worldwide. They are a testament to the hard work and dedication of every WuXi XDC employee – their relentless efforts that have made this milestone possible. It also belongs to our valued partners, whose trust and collaboration have driven our collective success. Looking ahead, WuXi XDC will continue to support our clients and advance the innovation and progress of the global bioconjugate industry." These awards follow WuXi XDC's recent recognition at the 2024 World ADC Awards, where the company was named Best CDMO Winner for the second consecutive year, further solidifying its leadership position in the global ADC industry. As the ADC market continues to experience sustainable growth, WuXi XDC relentlessly committed to advancing its technological capabilities and expanding its service offerings to meet clients' evolving needs. About WuXi XDC WuXi XDC Cayman Inc. ("WuXi XDC", stock code: is a leading global CRDMO focused on antibody drug conjugates (ADC) and the broader bioconjugate market. It provides end-to-end contract research, development and manufacturing services for bioconjugates, including ADCs. Its services cover antibody intermediates and other biologics intermediates, chemical payloads and linkers, as well as bioconjugate drug substances and drug products. For more information about WuXi XDC, please visit: WuXi XDC Contacts Investor: Media: wuxixdc_pr@ BD: wuxixdc_info@ View original content to download multimedia: SOURCE WuXi XDC
Yahoo
12-03-2025
- Business
- Yahoo
WuXi XDC and AbTis collaborate on antibody-drug conjugates
Contract research, development and manufacturing organisation (CRDMO) WuXi XDC Cayman has signed a memorandum of understanding with South Korea-based AbTis to advance next-generation antibody-drug conjugates (ADCs). The partnership combines AbTis' AbClick site-selective conjugation platform with WuXi XDC's all-in-one development and manufacturing platform and discovery services. AbClick leverages affinity peptide-assisted linkers for precise antibody-drug conjugation. To expedite ADC therapeutic innovation, the collaboration will incorporate AbTis' technology into WuXi XDC's toolbox. With the improvement of chemistry, manufacturing and controls (CMC) platform offerings, WuXi XDC and AbTis will enable clients to expedite the selection of preclinical candidates and the timelines of CMC development, as well as develop ADCs. WuXi XDC will enable potential partnerships between AbTis and its network of clients. WuXi XDC CEO Dr Jimmy Li stated: 'This collaboration with AbTis underscores our commitment to advancing innovation through strategic partnerships and creating meaningful value for our clients. 'With the addition of AbTis' innovative conjugation technology into the WuXi XDC technology suite, it will provide our clients with broader options of advanced bioconjugation technologies and tailormade solutions to support the advancement of next-generation ADCs and bioconjugate drugs.' The initiative will widen the reach of AbTis technologies globally and pave the way for synergistic market opportunities. AbTis CEO Dr Tae Dong Han stated: 'This partnership with WuXi XDC marks a significant milestone for AbTis as we expand the reach of our site-selective conjugation technology. 'By leveraging WuXi XDC's extensive global network and integrated CRDMO platforms alongside AbTis' innovative bioconjugation technologies and comprehensive expertise, we aim to create a synergy that amplifies the accessibility and impact of our innovations.' "WuXi XDC and AbTis collaborate on antibody-drug conjugates" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
